Kisho

Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy

neutropenia News | Kisho

Kisho

Not rare diseases news,
news about your rare disease.

Earlier

A case report details papiliotrema laurentii fungemia in a neutropenic patient, highlighting limited susceptibility to echinocandins. This finding underscores the need for awareness of rare fungal infections in immunocompromised individuals.

Recent research identifies autosomal dominant gain-of-function mutations in the LCP1 gene as the cause of a new syndromic neutropenia and immunodeficiency. This discovery enhances understanding of the genetic basis for these conditions and may inform future therapeutic strategies.

Enrollment in MacroGenics' gynecologic cancer study is temporarily paused following a patient death linked to severe neutropenia and septic shock. This incident raises safety concerns that could impact the trial's progress.

Not rare diseases news,news about your rare disease.

Earlier

A case report details papiliotrema laurentii fungemia in a neutropenic patient, highlighting limited susceptibility to echinocandins. This finding underscores the need for awareness of rare fungal infections in immunocompromised individuals.

Recent research identifies autosomal dominant gain-of-function mutations in the LCP1 gene as the cause of a new syndromic neutropenia and immunodeficiency. This discovery enhances understanding of the genetic basis for these conditions and may inform future therapeutic strategies.

Enrollment in MacroGenics' gynecologic cancer study is temporarily paused following a patient death linked to severe neutropenia and septic shock. This incident raises safety concerns that could impact the trial's progress.

Not rare diseases news,
news about your rare disease.